Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross‐Sectional Population‐Based Study
Authors' conclusion
CKD is common amongst Israeli adults with Type 2 diabetes and is strongly linked to cardiovascular and other diabetes-related complications. More advanced CKD stages correspond to substantially higher healthcare utilisation, reflecting escalating healthcare burden with CKD progression.
Study context
- Population
- Adults with T2D, national health organisation in Israel; Chronic kidney disease (CKD) defined by estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio
- Participants
- 62,661 adults
- Exposure
- CKD risk levels vs no CKD
- Outcome
- Prevalence of CKD across severity levels
Methodological detailspopulation-based, electronic medical records
- Population-based
- Electronic medical records
Main finding
As reported in the abstract
Prevalence of CKD
- Met criteria for CKD
- 30.7%
Observational data: associations, not effects.
Further findings
| Outcome | Adjusted prevalence ratio (95% CI) | |
|---|---|---|
| HF (strongest relationship with CKD level among CVD morbidity)Severe CKDvs No CKDMost advanced stagevs no CKD | 2.4 (2.3–2.6) | |
| RetinopathySevere CKDvs No CKD | 2.0 (1.9–2.1) | |
| NeuropathySevere CKDvs No CKD | 1.4 (1.3–1.5) | |
| 0.20.5125Adjusted prevalence ratio (log scale) |
HF (strongest relationship with CKD level among CVD morbidity)
- Higher CKD level associated with greater cardiovascular morbidity
Medication use
- Metformin, lipid-lowering agents and ACE inhibitors/ARBs were the most frequently used medications
Healthcare utilisation
- With CKD progression, nephrology, endocrinology and cardiology consultations, ED visits and hospitalisations rose
Original publication
Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross‐Sectional Population‐Based Study. Diabetes Obes Metab. Published 3 June 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →